- Home
- Products
FASENRA (Benralizumab)
FASENRA (Benralizumab)
- Medicine Name: Fasenra
- Generic Name: Benralizumab
- Dosage Form & Strength: 30 mg/mL, single-dose prefilled syringe (subcutaneous injection)
- Manufactured By: AstraZeneca
- FDA Approval: Yes (Initial approval: November 14, 2017)
Fasenra (Benralizumab) is a monoclonal antibody that targets the interleukin-5 receptor alpha. It is used as an add-on maintenance treatment for:
- Severe eosinophilic asthma in patients aged 12 years and older
Limitations of Use:
- Not for the treatment of other eosinophilic conditions
- Not indicated for acute bronchospasm or status asthmaticus
Recommended Dosage:
- Initial Phase: 30 mg subcutaneously every 4 weeks (3 doses)
- Maintenance Phase: 30 mg subcutaneously every 8 weeks
- Administer in the upper arm, thigh, or abdomen by a healthcare professional
- Hypersensitivity: Reactions such as rash, angioedema, and anaphylaxis may occur. Discontinue if observed.
- Not for acute symptoms: Do not use for immediate asthma relief.
- Steroid Tapering: Avoid abrupt withdrawal of systemic/inhaled corticosteroids.
- Helminth Infections: Treat any parasitic infections before initiating therapy; discontinue Fasenra if infections persist despite treatment.
- Delayed Reactions: Hypersensitivity may occur hours or days after use.
Documents Required for Import to India:
- Valid prescription from a registered doctor
- Patient’s diagnostic reports
- Government-issued ID proof
📍 Available In: Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Pune, Kolkata, Ahmedabad, Lucknow, and other major cities across India.
📞 Phone / WhatsApp: +91-99675 15602
📧 Email: info@globalraremeds.com
Global Rare Meds ensures:
- Authentic sourcing from the USA, UK, Canada, Europe, and Australia
- Fulfillment through our Ambernath, Thane District center
- Secure and temperature-controlled global shipping
- Support from licensed pharmacists for prescription validation
- 100% transparency and compliance with import laws
Q: What is Fasenra used for?
A: Fasenra is prescribed as an add-on treatment for patients with severe eosinophilic asthma.
Q: What is the active ingredient in Fasenra?
A: Benralizumab.
Q: Is Fasenra FDA approved?
A: Yes, it was approved by the FDA on November 14, 2017.
Q: How is Fasenra administered?
A: Subcutaneously via a prefilled syringe in the upper arm, thigh, or abdomen by a healthcare provider.
Q: What are the common side effects?
A: Headache and sore throat (pharyngitis) are commonly reported.
Q: How should Fasenra be stored?
A: Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton. Do not freeze or shake.
Q: Can I buy Fasenra online in India?
A: Yes. Fasenra can be imported via Global Rare Meds with a valid prescription if unavailable locally.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
